Docoh
Loading...

ABC Amerisource Bergen

AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work-and powered by our 22,000 associates-we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500, with more than $185 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries.

Company profile

Ticker
ABC
Exchange
CEO
Steven Collis
Employees
Incorporated
Location
Fiscal year end
Former names
AMERISOURCE BERGEN CORP
SEC CIK
Subsidiaries
Amerisource Receivables Financial Corporation • AmerisourceBergen Drug Corporation • AmerisourceBergen Global Holdings GmbH • AmerisourceBergen Global Manufacturer Services GmbH • AmerisourceBergen Group AG • AmerisourceBergen International Holdings Inc. • AmerisourceBergen Luxembourg S.a.r.L. • AmerisourceBergen Services Corporation • AmerisourceBergen Specialty Group, LLC • ASD Specialty Healthcare, LLC ...
IRS number
233079390

ABC stock data

(
)

Calendar

4 Aug 21
23 Oct 21
30 Sep 22
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Sep 20 Sep 19 Sep 18 Sep 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 2.68B 2.68B 2.68B 2.68B 2.68B 2.68B
Cash burn (monthly) 1.32B 61.54M (positive/no burn) 360.07M (positive/no burn) (positive/no burn)
Cash used (since last report) 4.99B 232.52M n/a 1.36B n/a n/a
Cash remaining -2.3B 2.45B n/a 1.32B n/a n/a
Runway (months of cash) -1.7 39.8 n/a 3.7 n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
12 Oct 21 Collis Steven H Common Stock Sell Dispose S No Yes 119.79 24,265 2.91M 184,579
12 Oct 21 Collis Steven H Common Stock Option exercise Acquire M No Yes 75.61 11,481 868.08K 208,844
12 Oct 21 Collis Steven H Common Stock Option exercise Acquire M No Yes 98.24 12,784 1.26M 197,363
12 Oct 21 Collis Steven H NQSO Common Stock Option exercise Dispose M No Yes 98.24 12,784 1.26M 51,135
12 Oct 21 Collis Steven H NQSO Common Stock Option exercise Dispose M No Yes 75.61 11,481 868.08K 183,680
20 Sep 21 Collis Steven H Common Stock Sell Dispose S No Yes 121.9 24,265 2.96M 184,579
20 Sep 21 Collis Steven H Common Stock Option exercise Acquire M No Yes 75.61 11,481 868.08K 208,844
20 Sep 21 Collis Steven H Common Stock Option exercise Acquire M No Yes 98.24 12,784 1.26M 197,363
20 Sep 21 Collis Steven H NQSO Common Stock Option exercise Dispose M No Yes 75.61 11,481 868.08K 195,161
20 Sep 21 Collis Steven H NQSO Common Stock Option exercise Dispose M No Yes 98.24 12,784 1.26M 63,919

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

91.6% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 762 736 +3.5%
Opened positions 99 89 +11.2%
Closed positions 73 104 -29.8%
Increased positions 259 268 -3.4%
Reduced positions 273 268 +1.9%
13F shares
Current Prev Q Change
Total value 21.79B 21.47B +1.5%
Total shares 190.39M 187.62M +1.5%
Total puts 690.8K 780.9K -11.5%
Total calls 669.55K 687.4K -2.6%
Total put/call ratio 1.0 1.1 -9.2%
Largest owners
Shares Value Change
WBA Walgreens Boots Alliance 58.85M $6.73B +3.5%
Vanguard 16.93M $1.94B +0.1%
BLK Blackrock 11.4M $1.31B -6.4%
JPM JPMorgan Chase & Co. 7.91M $905.6M +6.9%
STT State Street 6.51M $745.78M +1.1%
Boston Partners 4.71M $538.84M -4.5%
FMR 3.65M $417.55M -5.3%
Capital Research Global Investors 3.42M $390.99M NEW
FIL 2.88M $330.25M -0.0%
Geode Capital Management 2.59M $296.23M +3.2%
Largest transactions
Shares Bought/sold Change
Capital Research Global Investors 3.42M +3.42M NEW
WBA Walgreens Boots Alliance 58.85M +2M +3.5%
RY Royal Bank Of Canada 581.82K -832.38K -58.9%
Citadel Advisors 1.33M +809.96K +157.1%
BLK Blackrock 11.4M -780.85K -6.4%
Amundi Pioneer Asset Management 0 -748.61K EXIT
ANTIPODES PARTNERS 0 -674.11K EXIT
Lazard Asset Management 21.73K -664.91K -96.8%
Beutel, Goodman & Co 1.71M -616.13K -26.5%
Amundi 601.66K +601.66K NEW

Financial report summary

?
Management Discussion
  • We now expect our revenue growth percentage to be in the low-double digits in fiscal 2021 due to the addition of Alliance Healthcare in June 2021. Our future revenue growth will continue to be affected by various factors, such as industry growth trends, including drug utilization, the introduction of new, innovative brand therapies, the likely increase in the number of generic drugs and biosimilars that will be available over the next few years as a result of the expiration of certain drug patents held by brand-name pharmaceutical manufacturers and the rate of conversion from brand products to those generic drugs and biosimilars, price inflation and price deflation, general economic conditions in the United States, competition within the industry, customer consolidation, changes in pharmaceutical manufacturer pricing and distribution policies and practices, increased downward pressure on government and other third-party reimbursement rates to our customers, changes in government rules and regulations, and the impact of the COVID-19 pandemic.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: agency, American, barring, breadth, categorized, clearinghouse, Columbia, Confidential, depth, disbursed, distributor, Egypt, Egyptian, entry, escrow, Evidence, exact, exemption, foreclose, foreclosed, forma, hierarchy, Joint, Lira, Native, noncontrolling, observable, opening, opposed, political, preliminarily, preliminary, pretax, pro, reconciliation, registration, sixty, Spring, sued, treasury, Turkey, Turkish
Removed: announcement, appeal, Carolina, certify, close, decline, delayed, framework, free, gain, implementation, inherent, manufacturing, minimal, negotiating, objective, outlined, previously, procedure, proposing, reaching, rebated, refiled, representing, reversed, Tennessee, utilize, withdrew